Tucker

How Do You Prove Your Back Injury Was Caused by a Car Accident?

Retrieved on: 
Tuesday, March 26, 2024
Medical record, Injury, Outline, Perception, Pressure, Documentation, Tucker, Medicine, Back injury, Personal injury

NEW YORK, March 26, 2024 /PRNewswire/ -- The aftermath of a car accident can leave any victims startled and shaken. Under these circumstances, most people are not thinking about providing evidence of their injuries for future use. However, evidence of injury is vital should the victim choose to bring a compensation claim forward.

Key Points: 
  • However, evidence of injury is vital should the victim choose to bring a compensation claim forward.
  • After an accident, any victims must seek immediate medical aid, regardless of their perception of the severity of their injuries.
  • If a victim has collected evidence of the accident scene and their injuries, their next move should be to hire an experienced car accident or personal injury attorney.
  • The attorneys at Tucker Lawyers are exceptionally knowledgeable in the fields of personal injury and car accident claims.

Tucker Powersports Expands E-Power Portfolio with Five New Segway Products

Retrieved on: 
Thursday, September 29, 2022
Safety, Control, TecTile, NFC, Partnership, TPE, Travel, Sport, LED, Tag, U. S. Kids Golf, Ford S-Max, Business development, Business, Road, Electric motor, Segway, Tucker

FORT WORTH, Texas, Sept. 29, 2022 /PRNewswire/ -- Tucker Powersports, a leader in electric powered adventure products, added several new products from Segway to its E-Power portfolio. The products include a moped/electric bike, a scooter, updated versions of the original Segway device for both adults and children and a go kart.

Key Points: 
  • FORT WORTH, Texas, Sept. 29, 2022 /PRNewswire/ -- Tucker Powersports, a leader in electric powered adventure products, added several new products from Segway to its E-Power portfolio.
  • The products include a moped/electric bike, a scooter, updated versions of the original Segway device for both adults and children and a go kart.
  • "Our partnership with Segway gives us access to a wonderful range of products for both kids and adults" said Jamie Kempinski, Tucker's Director of Business Development.
  • Tucker's new offerings from Segway, as well as the other exciting E-Power products are now available at Tucker dealers around the United States.

Cenovus announces shareholder returns plan, triples dividend

Retrieved on: 
Wednesday, April 27, 2022
Convention (norm), Board, Public expenditure, Husky Lloydminster Refinery, AECO, WTI, COVID-19, Risk management, Advisory, Oil sands, Wood River, Sale, Program, Upgrader, Growth, Tucker, Contract, Environment, Maintenance, Downstream, Income, Lima, Acquisition, Financial services, Bank, Renewable energy, Holding company, Life insurance, Oil, Superior, Cenovus Energy, Upstream, Wembley

Cenovus will continue to maintain capital discipline, with the five-year business plan outlined at the companys Investor Day in December 2021 remaining in place and instrumental to growing shareholder returns.

Key Points: 
  • Cenovus will continue to maintain capital discipline, with the five-year business plan outlined at the companys Investor Day in December 2021 remaining in place and instrumental to growing shareholder returns.
  • Where the value of share buybacks in a quarter is greater than the targeted value of returns, no variable dividend will be paid for that quarter.
  • Cenovus recorded net earnings of $1.6 billion in the first quarter, compared with a net loss of $408 million in the fourth quarter.
  • The following table provides details on planned turnaround activities at Cenovus assets in 2022 and anticipated production or throughput impacts.

Tucker Powersports Launches Ambitious 100+ City ePower Experience Tour

Retrieved on: 
Wednesday, March 16, 2022
Safety, Business development, LED, City, Fantic Motor, Fuell, Multimedia, UBCO, EPower Engine Systems, Sale, EAV, Host, Business, Textile, Rail transport, Tucker

FORT WORTH, Texas, March 16, 2022 /PRNewswire/ -- Tucker Powersports today announced the industry's most extensive effort to expose dealers and customers to electric mobility products from its ePower portfolio. The Tucker ePower Experience will launch this month and make stops in over 100 cities around the United States offering test rides and product information on five of the program's brands. Stops will be at powersports dealerships and staffed by Tucker reps along with brand ambassadors and representatives from some of the participating companies.

Key Points: 
  • Tucker will execute the tour with four event rigs, each one with a full complement of ePower vehicles and point-of-sale information.
  • "The Tucker ePower Experience is the easiest way for powersports dealers to understand the opportunity that exists with electric mobility products," said Jamie Kempinski, Tucker's Director of Business Development.
  • A full, and expanding, schedule of tour stops is available on the ePower page of the Tucker website.
  • Dealers interested in hosting the Tucker ePower Experience should contact their Tucker representative.

Waterous Energy Fund Closes Its Fourth Equity Capital Raise, Acquires Caltex Resources Ltd. and the Tucker Thermal Oil Property, and Amalgamates Caltex and Tucker with Strathcona Resources Ltd.

Retrieved on: 
Monday, March 14, 2022
Energy, Professional Services, Oil, Gas, Finance, TD, RBC Capital Markets, Natural gas, ESG, Investment, Orion, Lindbergh, Acquisition, WTI, TD Securities, Capital, LLP, Atlantic-Pacific Capital, BMO Capital Markets, WEF, CEO, Oil, Security (finance), Renewable energy, Caltex, Tucker, Cold Lake

Waterous Energy Fund (WEF) today announced the closing of the amalgamation of Strathcona Resources Ltd. (Strathcona), Caltex Resources Ltd. (Caltex), and the Tucker thermal oil property (Tucker).

Key Points: 
  • Waterous Energy Fund (WEF) today announced the closing of the amalgamation of Strathcona Resources Ltd. (Strathcona), Caltex Resources Ltd. (Caltex), and the Tucker thermal oil property (Tucker).
  • On January 31, 2022, WEF closed its fourth capital raise (approximately C$345 million) to fund the acquisitions of Caltex and Tucker.
  • Since its founding in 2017, WEF has invested approximately C$2.0 billion of private equity capital through four capital raises.
  • About Waterous Energy Fund: Waterous Energy Fund is a Calgary-based energy investment firm with offices in Houston and New York.

Tucker Powersports Becomes Exclusive Distributor for FUELL Inc's E-Bikes and Accessories

Retrieved on: 
Monday, March 7, 2022
Carbon, Buell, Business development, Leadership, EPower Engine Systems, Name, Torque, CTO, Knowledge, Fuell, Business, Tucker, Multimedia, EBR, Technology, Partnership, Textile

FORT WORTH, Texas, March 7, 2022 /PRNewswire/ -- Tucker Powersports today announced an exclusive agreement with FUELL, Inc which names Tucker as the exclusive distributor of FUELL's complete line of premium Flluid e-Bikes as well as FUELL's branded accessories and replacement parts.

Key Points: 
  • FORT WORTH, Texas, March 7, 2022 /PRNewswire/ -- Tucker Powersports today announced an exclusive agreement with FUELL, Inc which names Tucker as the exclusive distributor of FUELL's complete line of premium Flluid e-Bikes as well as FUELL's branded accessories and replacement parts.
  • FUELL recently launched its line of three e-Bikes, the FUELL Flluid-1 (20 mph max speed), Flluid-1S (28mph with Shimano Hub) and Flluid-1E (28mph with Enviolo CVT).
  • Fuell's products will join Tucker's expanding portfolio of ePower products, which now includes e-Bikes, e-Scooters, electric skateboards and utility/adventure bikes.
  • FUELL products will be available to Tucker Powersports dealers this month.

Cenovus announces sale of Tucker asset for $800 million

Retrieved on: 
Thursday, December 16, 2021
International Accounting Standards Board, Tucker, Toronto Stock Exchange, IFRS, CVE, NYSE, Private Securities Litigation Reform Act, Sale, Industry, Perception, Marketing, International Accounting Standards Committee, Natural gas, International, Legislation, MD, GLOBE, GAAP, TSX, News, Bank, Oil, Risk management, Cenovus Energy

CALGARY, Alberta, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) has reached an agreement to sell its Tucker thermal asset for total cash proceeds of $800 million.

Key Points: 
  • CALGARY, Alberta, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) has reached an agreement to sell its Tucker thermal asset for total cash proceeds of $800 million.
  • Including this transaction, the company expects to realize almost $2 billion of total proceeds from asset sales announced in 2021.
  • This is yet another example of Cenovus seizing opportunities to generate incremental value for shareholders, said Alex Pourbaix, Cenovuss President & Chief Executive Officer.
  • Cenovuss corporate guidance dated December 7, 2021 does not reflect this asset sale.

Cocrystal Pharma to Discuss Progress with COVID-19 Antiviral Programs and Clinical Strategy During Noble Capital Markets’ Channelchek Virtual Roadshow

Retrieved on: 
Thursday, December 2, 2021
Research, Private Securities Litigation Reform Act, Cros, Government, Risk, Capital market, Annual report, Drug discovery, Norovirus, Severe acute respiratory syndrome coronavirus 2, IND, SEC, FINRA, Vaccine, COVID-19, Animal, Cocrystal, Goal, Omicron, Software, Nasdaq, GLOBE, CRO, Noble, CFO, Nobel Prize, COCP, FDA, Delta, Webcast, CMOS, Pharmaceutical industry, Security (finance)

The Cocrystal company overview will be followed by a question-and-answer session moderated by Noble Capital Markets Senior Research analyst Robert LeBoyer and will feature questions submitted by the audience.

Key Points: 
  • The Cocrystal company overview will be followed by a question-and-answer session moderated by Noble Capital Markets Senior Research analyst Robert LeBoyer and will feature questions submitted by the audience.
  • We are working diligently toward initiating clinical studies in 2022 with two promising COVID-19 protease inhibitors, said Dr. Lee.
  • Our antiviral inhibitors have shown broad-spectrum activity in vitro against COVID-19 and its variants, including the now predominant Delta variant.
  • Research on Channelchek is provided by Noble Capital Markets, Inc., an SEC / FINRA registered broker-dealer since 1984.

Cocrystal Pharma Presents Preclinical Data from COVID-19 Antiviral Programs and Outlines Near-Term Clinical Plans at the World Antiviral Congress 2021

Retrieved on: 
Wednesday, December 1, 2021
Patient, Private Securities Litigation Reform Act, Cros, Government, Safety, Risk, Technology, Annual report, Protease, Viral load, Norovirus, Severe acute respiratory syndrome coronavirus 2, SEC, Doctor of Philosophy, Pharmacokinetics, Vaccine, COVID-19, Cocrystal, Orthomyxoviridae, Omicron, Nasdaq, Research, GLOBE, Middle East respiratory syndrome–related coronavirus, Nobel Prize, COCP, Lead, United, FDA, Food, CMOS, Open Secrets: India's Intelligence Unveiled, Pharmaceutical industry

BOTHELL, Wash., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company, today presented favorable preclinical data from its COVID-19 programs and outlined its clinical plans to advance two antiviral compounds at the World Antiviral Congress 2021 in San Diego. The presentation, “Discovery of Oral, Broad-Spectrum SARS-CoV-2 MproInhibitors: Advancing to Clinical Development,” was delivered by Cocrystal President and co-interim CEO Sam Lee, PhD and is available here.

Key Points: 
  • Within the COVID-19 programs, he discussed in vitro and in vivo properties of Cocrystals intranasal and oral main protease (Mpro) inhibitors and its clinical development plans.
  • Our SARS-CoV-2 protease inhibitors showed broad-spectrum antiviral activity against Alpha, Beta, Delta, and Gamma variants in vitro.
  • In addition, our high resolution cocrystal structures using our proprietary platform technology further confirmed these results, said Dr. Lee.
  • The World Antiviral Congress 2021 provides a venue for discussing antiviral vaccines, immunotherapies and antiviral therapies.

Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development Programs and Milestones

Retrieved on: 
Monday, November 15, 2021
CRO, Clinical trial, Food, COVID-19, Regulation of tobacco by the U.S. Food and Drug Administration, Infection, Plasma protein binding, HCV, Mouse, Gastroenteritis, Protease, Safety, Centers for Disease Control and Prevention, Nobel Prize, Technology, CDC, Research, GLOBE, FDA, CMOS, WHO, G&A, Private Securities Litigation Reform Act, Cocrystal, Cirrhosis, R, CEO, World, Degenerative disease, Liver, Goal, United, Influenza, Program, Animal, Cros, Hepatocellular carcinoma, Vaccine, SEC, COCP, Government, Merck, World Health Organization, Risk, Severe acute respiratory syndrome coronavirus 2, Software, Annual report, Partnership, Company, Center, Enzyme, Nasdaq, CFO, Death, Pharmaceutical industry

Regarding our influenza programs, our supplier is manufacturing our novel PB2 inhibitor CC-42344 for pandemic and seasonal influenza A.

Key Points: 
  • Regarding our influenza programs, our supplier is manufacturing our novel PB2 inhibitor CC-42344 for pandemic and seasonal influenza A.
  • With the influenza A/B program, we anticipate providing an update on the development of the compounds jointly discovered with Merck using our technology platform in the first quarter 2022.
  • We are aggressively pursuing the advancement of these potent compounds as we navigate a challenging global supply chain.
  • As anticipated, Cocrystal reported no revenues for the third quarter of 2021 compared with $489,000 in revenues for the third quarter of 2020.